Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival

Viruses

Volumn 4, Issue 9, 2012, Pages 1537-1547

  Frappier, Lori ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

EBNA1; NF B; Nm23 H1; Oxidative stress; p53; PML; ROS; STAT1; Survivin; USP7

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; NUCLEOSIDE DIPHOSPHATE KINASE A; PROTEIN P53; SURVIVIN;

ANTIGEN EXPRESSION; APOPTOSIS; CARCINOGENICITY; CELL CYCLE ARREST; CELL IMMORTALIZATION; CELL MIGRATION; CELL NUCLEUS INCLUSION BODY; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; DISEASE ASSOCIATION; DNA DAMAGE; MODULATION; NONHUMAN; OXIDATIVE STRESS; PROMYELOCYTIC LEUKEMIA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; TRANSCRIPTION INITIATION; VIRUS CARCINOGENESIS;

CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; ONCOGENE PROTEINS; VIRULENCE FACTORS;

HUMAN HERPESVIRUS 4;

EID: 84867026753     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v4091537     Document Type: Review

References (67)

1. Klein, G. Viral latency and transformation: The strategy of Epstein-Barr virus. Cell 1989, 58, 5-8. doi:10.1016/0092-8674(89)90394-2
2. Thorley-Lawson, D.A.; Gross, A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 2004, 350, 1328-1337. doi:10.1056/NEJMra032015
3. Yates, J.L.; Warren, N.; Sugden, B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985, 313, 812-815. doi:10.1038/313812a0
4. Lupton, S.; Levine, A.J. Mapping of genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol. Cell. Biol. 1985, 5, 2533-2542.
5. Reisman, D.; Yates, J.; Sugden, B. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 1985, 5, 1822-1832.
6. Rawlins, D.R.; Milman, G.; Hayward, S.D.; Hayward, G.S. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA1) to clustered sites in the plasmid maintenance region. Cell 1985, 42, 859-868. doi:10.1016/0092-8674(85)90282-X
7. Frappier, L. EBNA1 in viral DNA replication and persistence. In Epstein-Barr Virus: Latency and Transformation; Robertson, E.S., Ed.; Caister Academic Press: Norwich, UK, 2010; pp. 37-59.
8. Gahn, T.; Sugden, B. An EBNA1 dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus lmp gene. J. Virol. 1995, 69, 2633-2636.
9. Reisman, D.; Sugden, B. Trans activation of an Epstein-Barr viral transcripitonal enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 1986, 6, 3838-3846.
10. Klein, G. Viral latency and transformation: The strategy of Epstein-Barr virus. Cell 1989, 58, 5-8. doi:10.1016/0092-8674(89)90394-2
11. Thorley-Lawson, D.A.; Gross, A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 2004, 350, 1328-1337. doi:10.1056/NEJMra032015
12. Hume, S.; Reisbach, G.; Feederle, R.; Delecluse, H.J.; Bousset, K.; Hammerschmidt, W.; Schepers, A. The EBV nuclear antigen 1 (EBNA 1) enhances B cell immortalization several thousand fold. Proc. Natl. Acad. Sci. U. S. A.2003, 100, 10989-10994.
13. Altmann, M.; Pich, D.; Ruiss, R.; Wang, J.; Sugden, B.; Hammerschmidt, W. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc. Natl. Acad. Sci. U. S. A. 2006,103, 14188-14193.
14. Kennedy, G.; Komano, J.; Sugden, B. Epstein-Barr virus provide a survival factor to Burkitt's lymphomas. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 14269-14274.
15. Hong, M.; Murai, Y.; Kutsuna, T.; Takahashi, H.; Nomoto, K.; Cheng, C.M.; Ishizawa, S.; Zhao, Q.L.; Ogawa, R.; Harmon, B.V. Suppression of Epstein-Barr nuclear antigen 1 (EBNA 1) by rna interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells. J. Cancer Res. Clin. Oncol. 2006, 132, 1-8.
16. Yin, Q.; Flemington, E.K. Sirnas against the Epstein-Barr virus latency replication factor, EBNA 1, inhibit its function and growth of EBV-dependent tumor cells. Virology 2006, 346, 385-393. doi:10.1016/j.virol.2005.11.021
17. Wilson, J.B.; Bell, J.L.; Levine, A.J. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 1996, 15, 3117-3126.
18. Tsimbouri, P.; Drotar, M.E.; Coy, J.L.; Wilson, J.B. Bcl-xL and rag genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes. Oncogene 2002, 21, 5182-5187. doi:10.1038/sj.onc.1205490
19. Kang, M.S.; Lu, H.; Yasui, T.; Sharpe, A.; Warren, H.; Cahir-McFarland, E.; Bronson, R.; Hung, S.C.; Kieff, E. Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic fvb mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 820-825.
20. Kang, M.S.; Soni, V.; Bronson, R.; Kieff, E. Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in c57bl/6j mice. J. Virol. 2008, 82, 4180-4183. doi:10.1128/JVI.02596-07
21. Kang, M.S.; Hung, S.C.; Kieff, E. Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 15233-15238.
22. Sheu, L.F.; Chen, A.; Meng, C.L.; Ho, K.C.; Lee, W.H.; Leu, F.J.; Chao, C.F. Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo. J. Pathol.1996, 180, 243-248. doi:10.1002/(SICI)1096-9896(199611)180:3<243::AID-PATH655>3.0.CO;2-7
23. Cheng, T.C.; Hsieh, S.S.; Hsu, W.L.; Chen, Y.F.; Ho, H.H.; Sheu, L.F. Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity. Int. J. Oncol.2010, 36, 151-160.
24. Kube, D.; Vockerodt, M.; Weber, O.; Hell, K.; Wolf, J.; Haier, B.; Grasser, F.A.; Muller-Lantzsch, N.; Kieff, E.; Diehl, V. Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of cd25 in the hodgkin cell line l428. J. Virol. 1999, 73, 1630-1636.
25. Kaul, R.; Murakami, M.; Choudhuri, T.; Robertson, E.S. Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model. J. Virol. 2007, 81, 10352-10361. doi:10.1128/JVI.00886-07
26. Holowaty, M.N.; Zeghouf, M.; Wu, H.; Tellam, J.; Athanasopoulos, V.; Greenblatt, J.; Frappier, L. Protein profiling with Epstein-Barr nuclear antigen 1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J. Biol. Chem. 2003, 278, 29987-29994.
27. Li, M.; Chen, D.; Shiloh, A.; Luo, J.; Nikolaev, A.Y.; Qin, J.; Gu, W. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 2002, 416, 648-653.
28. Li, M.; Brooks, C.L.; Kon, N.; Gu, W. A dynamic role of HAUSP in the p53-mdm2 pathway. Mol. Cell 2004, 13,879-886.
29. Cummins, J.M.; Rago, C.; Kohli, M.; Kinzler, K.W.; Lengauer, C.; Vogelstein, B. Tumour suppression: Disruption of HAUSP gene stabilizes p53. Nature 2004, 428, 486-487.
30. Holowaty, M.N.; Sheng, Y.; Nguyen, T.; Arrowsmith, C.; Frappier, L. Protein interaction domains of the ubiqutin specific protease, USP7/HAUSP. J. Biol. Chem. 2003, 278, 47753-47761.
31. Saridakis, V.; Sheng, Y.; Sarkari, F.; Holowaty, M.N.; Shire, K.; Nguyen, T.; Zhang, R.G.; Liao, J.; Lee, W.; Edwards, A.M. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol. Cell 2005, 18, 25-36.
32. Sheng, Y.; Saridakis, V.; Sarkari, F.; Duan, S.; Wu, T.; Arrowsmith, C.H.; Frappier, L. Molecular recognition of p53 and mdm2 by USP7/HAUSP. Nat. Struct. Mol. Biol. 2006, 13, 285-291. doi:10.1038/nsmb1067
33. Hu, M.; Gu, L.; Li, M.; Jeffrey, P.D.; Gu, W.; Shi, Y. Structural basis of competitive recognition of p53 and mdm2 by HAUSP/USP7: Implications for the regulation of the p53-mdm2 pathway. PLoS Biol. 2006, 4, e27.
34. Sivachandran, N.; Sarkari, F.; Frappier, L. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog. 2008, 4, e1000170. doi:10.1371/journal.ppat.1000170
35. Sivachandran, N.; Dawson, C.W.; Young, L.S.; Liu, F.F.; Middeldorp, J.; Frappier, L. Contributions of the Epstein-Barr virus EBNA 1 protein to gastric carcinoma. J. Virol. 2012, 86, 60-68. doi:10.1128/JVI.05623-11
36. Salomoni, P.; Ferguson, B.J.; Wyllie, A.H.; Rich, T. New insights into the role of PML in tumour suppression. Cell Res. 2008, 18, 622-640. doi:10.1038/cr.2008.58
37. Bernardi, R.; Pandolfi, P.P. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 2007, 8, 1006-1016. doi:10.1038/nrm2277
38. Takahashi, Y.; Lallemand-Breitenbach, V.; Zhu, J.; de The, H. PML nuclear bodies and apoptosis. Oncogene2004, 23, 2819-2824. doi:10.1038/sj.onc.1207533
39. Guo, A.; Salomoni, P.; Luo, J.; Shih, A.; Zhong, S.; Gu, W.; Pandolfi, P.P. The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2000, 2, 730-736. doi:10.1038/35036365
40. Wang, Z.G.; Ruggero, D.; Ronchetti, S.; Zhong, S.; Gaboli, M.; Rivi, R.; Pandolfi, P.P. PML is essential for multiple apoptotic pathways. Nat. Genet. 1998, 20, 266-272. doi:10.1038/3073
41. Pearson, M.; Carbone, R.; Sebastiani, C.; Cioce, M.; Fagioli, M.; Saito, S.; Higashimoto, Y.; Appella, E.; Minucci, S.; Pandolfi, P.P. PML regulates p53 acetylation and premature senescence induced by oncogenic ras. Nature 2000,406, 207-210. doi:10.1038/35018127
42. Gurrieri, C.; Capodieci, P.; Bernardi, R.; Scaglioni, P.P.; Nafa, K.; Rush, L.J.; Verbel, D.A.; Cordon-Cardo, C.; Pandolfi, P.P. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J. Natl. Cancer Inst. 2004, 96, 269-279. doi:10.1093/jnci/djh043
43. Geoffroy, M.C.; Chelbi-Alix, M.K. Role of promyelocytic leukemia protein in host antiviral defense. J. Interf. Cytokine Res. 2011, 31, 145-158. doi:10.1089/jir.2010.0111
44. Everett, R.D.; Chelbi-Alix, M.K. PML and PML nuclear bodies: Implications in antiviral defence. Biochimie 2007,89, 819-830. doi:10.1016/j.biochi.2007.01.004
45. Reichelt, M.; Wang, L.; Sommer, M.; Perrino, J.; Nour, A.M.; Sen, N.; Baiker, A.; Zerboni, L.; Arvin, A.M. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus. PLoS Pathog. 2011, 7, e1001266.
46. Everett, R.D. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 2001, 20, 7266-7273. doi:10.1038/sj.onc.1204759
47. Sivachandran, N.; Cao, J.Y.; Frappier, L. Epstein-Barr virus nuclear antigen 1 hijacks the host kinase CK2 to disrupt PML nuclear bodies. J. Virol. 2010, 84, 11113-11123. doi:10.1128/JVI.01183-10
48. Sivachandran, N.; Wang, X.; Frappier, L. Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection. J. Virol. 2012, 86, 6146-6158. doi:10.1128/JVI.00013-12
49. Scaglioni, P.P.; Yung, T.M.; Cai, L.F.; Erdjument-Bromage, H.; Kaufman, A.J.; Singh, B.; Teruya-Feldstein, J.; Tempst, P.; Pandolfi, P.P. A CK2-dependent mechanism for degradation of thePML tumor suppressor. Cell 2006,126, 269-283. doi:10.1016/j.cell.2006.05.041
50. Scaglioni, P.P.; Yung, T.M.; Choi, S.C.; Baldini, C.; Konstantinidou, G.; Pandolfi, P.P. CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor. Mol. Cell Biochem. 2008, 316,149-154. doi:10.1007/s11010-008-9812-7
51. Sarkari, F.; Wang, X.; Nguyen, T.; Frappier, L. The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies. PLoS One 2011, 6, e16598.
52. Sides, M.D.; Block, G.J.; Shan, B.; Esteves, K.C.; Lin, Z.; Flemington, E.K.; Lasky, J.A. Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells. Virology 2011, 416, 86-97. doi:10.1016/j.virol.2011.04.005
53. Wood, V.H.; O'Neil, J.D.; Wei, W.; Stewart, S.E.; Dawson, C.W.; Young, L.S. Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFβ signaling pathways. Oncogene2007, 26, 4135-4147.
54. Kim, H.S.; Lee, M.S. STAT1 as a key modulator of cell death. Cell. Signal. 2007, 19, 454-465. doi:10.1016/j.cellsig.2006.09.003
55. Flavell, J.R.; Baumforth, K.R.; Wood, V.H.; Davies, G.L.; Wei, W.; Reynolds, G.M.; Morgan, S.; Boyce, A.; Kelly, G.L.; Young, L.S. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA 1 contributes to the growth and survival of hodgkin lymphoma cells. Blood 2008, 111, 292-301. doi:10.1182/blood-2006-11-059881
56. Valentine, R.; Dawson, C.W.; Hu, C.; Shah, K.M.; Owen, T.J.; Date, K.L.; Maia, S.P.; Shao, J.; Arrand, J.R.; Young, L.S. Epstein-Barr virus-encoded EBNA 1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation. Mol. Cancer 2010, 9, doi:10.1186/1476-4598-9-1
57. Avery, S.V. Molecular targets of oxidative stress. Biochem. J. 2011, 434, 201-210. doi:10.1042/BJ20101695
58. Lassoued, S.; Ben Ameur, R.; Ayadi, W.; Gargouri, B.; Ben Mansour, R.; Attia, H. Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. Mol. Cell Biochem. 2008, 313, 179-186. doi:10.1007/s11010-008-9755-z
59. Cerimele, F.; Battle, T.; Lynch, R.; Frank, D.A.; Murad, E.; Cohen, C.; Macaron, N.; Sixbey, J.; Smith, K.; Watnick, R.S. Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 175-179.
60. Gruhne, B.; Sompallae, R.; Marescotti, D.; Kamranvar, S.A.; Gastaldello, S.; Masucci, M.G. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 2313-2318.
61. Kamranvar, S.A.; Masucci, M.G. The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress. Leukemia 2011, 25, 1017-1025. doi:10.1038/leu.2011.35
62. Cao, J.Y.; Mansouri, S.; Frappier, L. Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA 1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses.J. Virol. 2012, 86, 382-394. doi:10.1128/JVI.05648-11
63. Murakami, M.; Lan, K.; Subramanian, C.; Robertson, E.S. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration. J. Virol. 2005, 79, 1559-1568. doi:10.1128/JVI.79.3.1559-1568.2005
64. Choudhuri, T.; Murakami, M.; Kaul, R.; Sahu, S.K.; Mohanty, S.; Verma, S.C.; Kumar, P.; Robertson, E.S. Nm23-H1 can induce cell cycle arrest and apoptosis in B cells. Cancer Biol. Ther. 2010, 9, 1065-1078. doi:10.4161/cbt.9.12.11995
65. Lu, J.; Murakami, M.; Verma, S.C.; Cai, Q.; Haldar, S.; Kaul, R.; Wasik, M.A.; Middeldorp, J.; Robertson, E.S. Epstein-Barr virus nuclear antigen 1 (EBNA 1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology 2011, 410, 64-75. doi:10.1016/j.virol.2010.10.029
66. Wu, H.; Kapoor, P.; Frappier, L. Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J. Virol. 2002, 76, 2480-2490. doi:10.1128/jvi.76.5.2480-2490.2002
67. Kennedy, G.; Sugden, B. EBNA 1, a bifunctional transcriptional activator. Mol. Cell Biol. 2003, 23, 6901-6908. doi:10.1128/MCB.23.19.6901-6908.2003